Compare Enphase Energy Inc (ENPH) vs GE HealthCare Technologies Inc. Common Stock (GEHC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enphase Energy Inc vs GE HealthCare Technologies Inc. Common Stock — how do they compare? Enphase Energy Inc trades at $28.99 (market cap $4.23B), while GE HealthCare Technologies Inc. Common Stock trades at $68.97 (market cap $31.07B). The key difference: GE HealthCare Technologies Inc. Common Stock is far larger — about 7.3× Enphase Energy Inc's market cap, and GE HealthCare Technologies Inc. Common Stock pays a 0.23% dividend while Enphase Energy Inc pays none. Which is the better fit depends on your goals.
| ENPH | GEHC | |
|---|---|---|
Market Cap | $4.23B | $31.07B |
Volume | 4,755,897 | 3,443,020 |
Sector | Energy | Health |
52-Week High | $72.33 | $88.16 |
52-Week Low | $26.12 | $59.48 |
Typical Hold Time | 72 Days | — |
Enterprise Value | $3.88B | $39.53B |
Dividend Yield | — | 0.23% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Enphase Energy (ENPH) trades at $32.03, up 1.71% on the day, with a bearish technical signal but oversold RSI suggesting potential for a bounce. Revenue declined to $1.47B in 2025 from $2.3B in 2023, though net income margin improved to 11.68%. Recent news highlights product approvals and AI infrastructure developments, yet the stock faces pressure from high borrowing costs impacting the solar sector.
The outlook is mixed: analyst consensus targets $42.68 (33% upside) with 42% buy ratings, but earnings misses and solar industry headwinds pose risks. Investment opportunity hinges on execution amid competitive and macroeconomic challenges, with current valuation at a P/E of 31.71 reflecting growth expectations.
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Enphase Energy Inc
Enphase Energy is a global energy technology company. The company delivers smart, easy-to-use solutions that manage solar generation, storage, and communication on one platform. The company's microinverter technology primarily serves the rooftop solar market and produces a fully integrated solar-plus-storage solution. Geographically, it derives a majority of revenue from the United States.
Read more on ENPH →About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →
